The 2015 event was quite simply one of the most successful meetings in its 15 year history.
Bringing together over 550 leading figures in the vaccine industry from pharma, biotech, government, academia and the wider service provider community, with the primary aim to discuss the scientific, clinical and strategic advances and opportunities provided by the growth of the vaccine industry.
It is the longest running event of its kind in North America and continues to be the leading annual gathering of vaccine decision makers focused on both scientific development and commercialisation networking opportunities.